# Jasper Therapeutics, Inc.: Form 8-K, filed Nov 4, 2022

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: 8-K
- Filed: 2022-11-04
- Accepted by EDGAR: Nov 4, 2022, 16:01 ET
- Period: 2022-11-03
- Accession: 0001213900-22-069368
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390022069368/ea168052-8k_jasperthera.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390022069368/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390022069368/ea168052-8k_jasperthera.htm

Filed Nov 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-069368. Last ingested by Listed: Nov 4, 2026, 08:12 ET. No prices; not investment advice.